New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 8, 2014
07:01 EDTNURONeuroMetrix says wearble technology for treatment of chronic pain cleared by FDA
NeuroMetrix announced that its wearable technology for treatment of chronic pain received 510(k) clearance from the U.S. Food and Drug Administration for over-the-counter use. The company is in late stage development of a consumer oriented chronic pain treatment product. The device is based on wearable technology, presently deployed in the company’s SENSUS Pain Management System, that utilizes comfortable, non-invasive electrical stimulation of sensory nerves to induce safe and effective pain relief. It is lightweight and can be worn during the day while active, and at night while sleeping. This 510(k) clearance allows the company to market the over-the-counter device through retail distribution channels without a prescription requirement.
News For NURO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2015
07:01 EDTNURONeuroMetrix issued U.S. patent for DPNCheck technology
NeuroMetrix announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,173,581. The patent covers the core technology deployed in the DPNCheck device. The claims cover the novel integrated design of the hand-held DPNCheck device that enables accurate and rapid measurement of sural nerve conduction, which is a standard neuropathy biomarker. Additional claims cover the automation algorithms and biosensors.
November 11, 2015
13:09 EDTNURONeuroMetrix granted AMPA Seal of Approval for Quell
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use